Filing Details
- Accession Number:
- 0001209191-20-006173
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-03 21:15:51
- Reporting Period:
- 2020-01-31
- Accepted Time:
- 2020-02-03 21:15:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899460 | Mannkind Corp | MNKD | Pharmaceutical Preparations (2834) | 133607736 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1732647 | M David Kendall | 30930 Russell Ranch Road Suite 300 Westlake Village CA 91362 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Acquisiton | 2020-01-31 | 2,304 | $0.95 | 52,154 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reporting person purchased shares through the Company's Employee Stock Purchase Plan on January 31, 2020.
Billionaire Hedge Funds
